Debbie Chen, MD

Title(s)Volunteer, Medicine
SchoolSchool of Medicine
Address533 Parnassus Avenue, #404
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABA06/2010Human Biology
    University of California, Davis School of Medicine, Sacramento, CAMD06/2016Medicine
    Massachusetts General Hospital, Boston, MAResidency06/2019Internal Medicine
    University of California, San Francisco, San Francisco, CAFellowshipPresentNephrology
    University of California, San Francisco, San Francisco, CAMASPresentClinical Research

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Personalizing Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Therapy in Chronic Kidney Disease
    NIH F32DK130543Jul 1, 2021 - Jun 30, 2023
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank. Kidney Med. 2024 Apr; 6(4):100796. Chen DC, Lu K, Scherzer R, Lees JS, Rutherford E, Mark PB, Potok OA, Rifkin DE, Ix JH, Shlipak MG, Estrella MM. PMID: 38567244; PMCID: PMC10986041.
      View in: PubMed   Mentions:
    2. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity. Am J Kidney Dis. 2024 Apr; 83(4):489-496.e1. Chen DC, Scherzer R, Ix JH, Kramer HJ, Crews DC, Nadkarni G, Gutierrez O, Bullen AL, Ilori T, Garimella PS, Shlipak MG, Estrella MM. PMID: 37866793; PMCID: PMC10960714.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank. J Am Heart Assoc. 2023 02 07; 12(3):e027079. Chen DC, Lees JS, Lu K, Scherzer R, Rutherford E, Mark PB, Kanaya AM, Shlipak MG, Estrella MM. PMID: 36695320; PMCID: PMC9973614.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    4. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease. JAMA Netw Open. 2022 10 03; 5(10):e2238300. Lees JS, Rutherford E, Stevens KI, Chen DC, Scherzer R, Estrella MM, Sullivan MK, Ebert N, Mark PB, Shlipak MG. PMID: 36282503; PMCID: PMC9597396.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    5. Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. Kidney360. 2022; 3(10):1807-1814. Chen DC, Potok OA, Rifkin DE, Estrella MM. View Publication.
    6. Advantages, Limitations, and Clinical Considerations in Using Cystatin C to Estimate GFR. Kidney360. 2022 10 27; 3(10):1807-1814. Chen DC, Potok OA, Rifkin D, Estrella MM. PMID: 36514729; PMCID: PMC9717651.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    7. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure. Am J Kidney Dis. 2022 12; 80(6):762-772.e1. Chen DC, Shlipak MG, Scherzer R, Bansal N, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM. PMID: 35817274; PMCID: PMC9691565.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    8. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality. JAMA Netw Open. 2022 02 01; 5(2):e2148940. Chen DC, Shlipak MG, Scherzer R, Bauer SR, Potok OA, Rifkin DE, Ix JH, Muiru AN, Hsu CY, Estrella MM. PMID: 35175342; PMCID: PMC8855239.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    9. The Impact of COVID-19 on Nephrology Fellows-A Perspective From the 2020-2021 AJKD Editorial Intern Class. Am J Kidney Dis. 2021 12; 78(6):769-771. Agarwal K, Rajasekaran A, Chen D, Holmes R. PMID: 34666922; PMCID: PMC8520117.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    10. Intensive BP Control and eGFR Declines: Are These Events Due to Hemodynamic Effects and Are Changes Reversible? Curr Cardiol Rep. 2020 08 09; 22(10):117. Chen DC, McCallum W, Sarnak MJ, Ku E. PMID: 32772196; PMCID: PMC7668315.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. Should Renin-Angiotensin System Blockade Be Avoided in Patients With Declining Kidney Function? Am J Kidney Dis. 2020 11; 76(5):739-741. Weir MR, Chen DC, Ku E. PMID: 32407751.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Fellow as Clinical Teacher (FACT) Curriculum: Improving Fellows' Teaching Skills During Inpatient Consultation. MedEdPORTAL. 2018 06 26; 14:10728. Chen DC, Miloslavsky EM, Winn AS, McSparron JI. PMID: 30800928; PMCID: PMC6342376.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    13. Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease. Catheter Cardiovasc Interv. 2018 06; 91(7):1308-1317. Yeo KK, Armstrong EJ, López JE, Chen DC, Westin GG, Li CS, Anderson D, Hua A, Singapuri A, Amsterdam EA, Chiamvimonvat N, Laird JR. PMID: 29411531; PMCID: PMC5997520.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease. Am J Cardiol. 2017 Apr 15; 119(8):1146-1152. Chen DC, Singh GD, Armstrong EJ, Waldo SW, Laird JR, Amsterdam EA. PMID: 28259239.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    15. Faces of Lyme. J Gen Intern Med. 2017 05; 32(5):583-584. Chen DC, Giglio BM, Aronowitz PB. PMID: 27957662; PMCID: PMC5400763.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Long-Standing Goiter Causing Acute Airway Compromise. J Gen Intern Med. 2016 12; 31(12):1539-1540. Chen DC, Williams DM, Aronowitz PB. PMID: 27173499; PMCID: PMC5130940.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Anti-metastatic action of FAK inhibitor OXA-11 in combination with VEGFR-2 signaling blockade in pancreatic neuroendocrine tumors. Clin Exp Metastasis. 2015 Dec; 32(8):799-817. Moen I, Gebre M, Alonso-Camino V, Chen D, Epstein D, McDonald DM. PMID: 26445848; PMCID: PMC4651821.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    18. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia. Vasc Med. 2015 Jun; 20(3):237-44. Armstrong EJ, Chen DC, Singh GD, Amsterdam EA, Laird JR. PMID: 25835349.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    19. Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease. Vasc Health Risk Manag. 2015; 11:185-92. Chen DC, Armstrong EJ, Singh GD, Amsterdam EA, Laird JR. PMID: 25767395; PMCID: PMC4354443.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    20. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc. 2014 Apr 10; 3(2):e000697. Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR. PMID: 24721799; PMCID: PMC4187469.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    21. Increased vascular delivery and efficacy of chemotherapy after inhibition of platelet-derived growth factor-B. Am J Pathol. 2011 Jun; 178(6):2920-30. Falcon BL, Pietras K, Chou J, Chen D, Sennino B, Hanahan D, McDonald DM. PMID: 21641409; PMCID: PMC3124291.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    Debbie's Networks
    Concepts (125)
    Derived automatically from this person's publications.
    Co-Authors (21)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department